Chronic kidney disease and the global NCDs agenda

2017 is an important year for the international nephrology community. March 9 was World Kidney Day, the theme this year being ‘Kidney disease and obesity: healthy lifestyles for healthy kidneys’, highlighting the crucial link between the kidneys and metabolic and cardiovascular health. In April, the Global Kidney Health Atlas, one of the largest health-related country capacity reviews in history, was launched at the World Congress of Nephrology in Mexico City. The Atlas, a first for the nephrology community, is a multinational cross-sectional survey designed to assess need and capacity for kidney care worldwide and provide the foundation for a global surveillance network for chronic kidney disease (CKD) care. CKD is an enormous public health issue, the tide of which continues to inexorably rise. In the 2015 Global Burden of Disease Study, kidney disease was the 12th most common cause of death, accounting for 1.1 million deaths worldwide.1 Overall CKD mortality has increased by 31.7% over the last 10 years, making it one of the fastest rising major causes of death, alongside diabetes and dementia.1 In the same study, CKD ranked as the 17th leading cause of global years lost of life, an 18.4% increase since 2005, and the third largest increase of any major cause of death.1 This is in stark contrast to other non-communicable diseases, for example cardiovascular disease and chronic obstructive pulmonary disease, where global years lost of life fell during the same time period (−10.2% and −3.0%, respectively).1 Unabated growth in the incidence of diabetic kidney disease, underpinned by a global imbalance between overnutrition and inadequate physical inactivity causing overweight and obesity, is the key driver of CKD burden. Between 2005 and 2015, the prevalence of diabetic kidney disease increased by 39.5% globally.1 In Mexico, the country with the highest CKD death rate in the world, …

[1]  David W. Johnson,et al.  Global Kidney Health Atlas (GKHA): design and methods. , 2017, Kidney international supplements.

[2]  Ashutosh Kumar Singh,et al.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.

[3]  Amit X Garg,et al.  Worldwide access to treatment for end-stage kidney disease: a systematic review , 2015, The Lancet.

[4]  Syed Saad,et al.  Assessment of Global Kidney Health Care Status , 2017, JAMA.

[5]  S. Agarwal,et al.  How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program. , 2014, Kidney international.

[6]  P. Schauer,et al.  Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[7]  Dan J Stein,et al.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, BDJ.

[8]  Ashutosh Kumar Singh,et al.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.

[9]  M. Woodward,et al.  Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England , 2017, PloS one.

[10]  M Arantxa Colchero,et al.  Beverage purchases from stores in Mexico under the excise tax on sugar sweetened beverages: observational study , 2016, British Medical Journal.

[11]  Bernadette A. Thomas,et al.  Global Cardiovascular and Renal Outcomes of Reduced GFR. , 2017, Journal of the American Society of Nephrology : JASN.

[12]  V. Mohan,et al.  Prevalence of chronic kidney disease and risk factors for its progression: A cross-sectional comparison of Indians living in Indian versus U.S. cities , 2017, PloS one.

[13]  V. Jha,et al.  Chronic kidney disease: global dimension and perspectives , 2013, The Lancet.